ESD

What Is ESD?

An advanced technique designed to remove selected large or early neoplastic lesions in one piece.

Endoscopic Submucosal Dissection (ESD) hasta rehberiİleri Endoskopi
01Typical durationDuration varies with the indication and treatment
02Comfort planSedation or anaesthesia is individually planned
03Observation / stayDay case or inpatient observation when clinically needed
04ResultsInitial findings the same day; pathology later
PHYSICIAN · EVIDENCE · EXPERIENCE

ESD and Assoc. Prof. Süleyman Günay

This page connects scientific guidance, relevant conditions and diagnostics, verifiable congress/live-case records involving Süleyman Günay, and the patient decision pathway. The records do not claim superiority or guarantee an outcome.

Open physician profile →Source-linked academic archive →
6scientific sources linked to this page17related verifiable academic records6connected patient-pathway guides
Invited speaker2nd Turkish-German Gastroenterology Meeting2026-09-12 · Open primary source ↗
EVIDENCE DEPTH · GUIDELINES · PEER-REVIEWED RESEARCH

ESD evidence review: lesion selection, en-bloc pathology and curative intent

ESD is more than a way to remove a large lesion without an external incision. Its clinical value is the ability, in appropriately selected superficial neoplasia, to achieve en-bloc resection that supports organ preservation and detailed pathological staging. That value depends on selecting a lesion with a realistic potential for curative endoscopic treatment and a low enough risk of deep invasion or nodal disease.

ESD is not a procedure that can be applied to every patient.

Doç. Dr. Süleyman GünayPhysician statement emphasising that ESD depends on appropriate patient and lesion selection.Translation note: the original statement is in Turkish.

1. ESD selection starts with optical staging and invasion risk, not size alone

The 2022 ESGE ESD guideline emphasises high-definition white-light examination and enhanced imaging when appropriate to define lesion borders, morphology and features associated with deeper invasion. The purpose is not merely to measure diameter. Surface and vascular pattern, ulceration or fibrosis, location and suspicion of deep submucosal invasion all influence whether endoscopic resection can be oncologically adequate. When deep invasion or meaningful nodal risk is suspected, surgery or multidisciplinary oncological assessment may provide the more appropriate pathway.

Simple rules such as “anything above two centimetres needs ESD” are therefore misleading. Oesophageal, gastric, colonic and rectal lesions have different biology and lymphatic risk. EMR can be appropriate for some favourable lesions, while ESD becomes valuable when en-bloc histology is critical or when lesion characteristics make piecemeal resection suboptimal. Previous biopsy or intervention-related fibrosis, location and circumferential extent also change technical difficulty and adverse-event risk.

2. Why en-bloc resection matters: the final treatment decision is completed by pathology

An important advantage of ESD is the potential to retrieve an intact specimen. This helps pathology assess horizontal and vertical margins, depth of invasion, differentiation and lymphovascular involvement—features that determine whether endoscopic therapy can be considered curative. A technically successful ESD is not automatically an oncologically curative ESD. Non-curative histology may still lead to surgery or additional oncological assessment.

This distinction needs to be explicit in patient information. The pathology report after resection can be more decisive than the initial visual impression because it determines whether follow-up alone is appropriate or further treatment is needed. A serious ESD page should therefore explain not only how the dissection is performed but also which pathology findings define curative resection and which findings trigger a new treatment discussion.

3. Evidence is organ-specific: gastric, oesophageal and colorectal ESD should not be reduced to one success rate

MAPS III 2025 updates the European pathway for gastric precancerous conditions and early neoplasia, while the 2024 ESGE colorectal guideline differentiates standard polypectomy, EMR and selected en-bloc/ESD strategies according to lesion features and expertise. Oesophageal resection raises additional issues such as stricture risk after extensive circumferential treatment. It is therefore inappropriate to quote one pooled “ESD success rate” as if it applied equally to every organ and lesion.

Bleeding and perforation are important early adverse events, but delayed strictures—particularly after extensive oesophageal resection—may also shape the plan. Safety is a system property: lesion selection, optical diagnosis, haemostasis, perforation closure capability, anaesthesia support, pathology quality and access to surgical rescue are all part of the outcome. The clinically meaningful question is not just “Can ESD be done?” but “Is ESD the right oncological and pathological strategy for this lesion?”

This evidence review is for general information. Guideline recommendations cannot be converted into an individual treatment recommendation without considering anatomy, comorbidities, previous therapy and current clinical findings.

From the patient perspective

What should you expect from this procedure?

1AssessmentRight indication
2PreparationFasting · medicines · support
3ProcedureSedation + treatment
4RecoveryObservation · debrief
5Follow-upResults · pathology · review
Quick view

What should be clear before, during and after the procedure?

WhenWhat to clarifyWhy it matters
BeforeFasting, medicines, blood thinners, escort and the purpose of the procedureAffects safety and planning
Procedure daySedation/anaesthesia, possible additional intervention and observation timeClarifies expectations and consent
AfterDiet, medicines, driving, results/pathology and warning signsSupports safe recovery and follow-up
Quick answer

An advanced technique designed to remove selected large or early neoplastic lesions in one piece. Suitability and preparation must be personalised after clinical review.

Expert summary

ESD aims to remove selected superficial gastrointestinal neoplasia or large dysplastic lesions in one piece, supporting organ-preserving treatment and detailed pathological staging. Borders and the likelihood of deep invasion are assessed before treatment. Non-curative histology may still require surgical or oncological therapy.

01

What is it?

An advanced technique designed to remove selected large or early neoplastic lesions in one piece.

It is planned as an individual clinical pathway based on symptoms, previous tests, anatomy and treatment goals. Suitability cannot be decided from a web page alone. Expected benefits, alternatives, sedation or anaesthesia and follow-up are discussed before consent. The goal is safe recovery and an appropriate long-term plan as well as technical success.

R
SECTION-LEVEL EVIDENCE

Evidence map for this guide

The organisations and guidelines used for each section are mapped below.

Overview5 sources
Decision6 sources
Indications6 sources
Preparation3 sources
Procedure6 sources
Aftercare3 sources
Alternatives5 sources
Risks5 sources
Follow-up6 sources
Urgent warnings3 sources
FAQ3 sources
02

How is this procedure selected?

The central ESD question is whether a lesion can be removed endoscopically with curative intent and acceptable risk. High-definition endoscopy, prior histology and selected EUS or cross-sectional imaging assess borders, depth and lymph-node risk. EMR may suit a smaller favourable lesion, while deep invasion or substantial nodal risk favours surgery. Location, fibrosis and circumferential extent affect bleeding, perforation and stricture risk.

Key principle

The clinical question—not the procedure name—drives the plan. If a simpler and safer method can answer the same question, it should be discussed first.

03

When is it considered?

This procedure may be considered in the situations below. The list is not a diagnosis or a treatment decision; test findings and individual risks must be interpreted together.

  • Symptoms or test findings related to this procedure
  • Need for detailed diagnosis, tissue sampling or endoscopic treatment
  • A specialist review showing that expected benefit outweighs individual risk
04

Preparation timeline

This is a general pathway. Your personalised written hospital instructions and medicine plan always take priority.

Before booking

Share your complete health history

Tell the team about blood thinners, diabetes medicines, allergies, pregnancy, heart or lung disease and previous anaesthesia problems. Never stop prescribed medicine without an individual plan.

Before the procedure

Follow your written preparation plan

Fasting, bowel preparation and medicine timing depend on the procedure and your health. The instructions from your treating unit take priority over general web information.

On the day

Bring records and arrange support

Bring imaging, reports and an up-to-date medicine list. If sedation is planned, arrange a responsible adult to take you home and do not drive.

Before discharge

Confirm the recovery plan

Ask about diet, medicines, expected symptoms, pathology results, follow-up and the warning signs that require urgent contact.

05

What happens during the procedure?

The exact steps depend on the indication and findings. Monitoring, comfort and safety continue throughout the procedure; any possible therapeutic step is discussed during consent.

1Identity and safety checks2Sedation or anaesthesia plan3Endoscopic procedure4Recovery and debrief
06

Aftercare and recovery

Recovery, diet, medicines and discharge are individualised. If tissue is obtained, arrange how and when the pathology result will be reviewed with the clinical team.

Ask before you leave

When can I eat? When do I restart medicines? Can I drive? Who will explain pathology results and when? When is follow-up?

07

Alternatives and comparison options

The same technique is not appropriate for every patient. These options may be compared according to the clinical question, anatomy, disease extent and general health.

  • Endoscopic mucosal resection (EMR) when lesion features permit
  • Endoscopic full-thickness resection or another advanced resection technique in selected lesions
  • Surgery when deep invasion, lymph-node risk or non-curative pathology is suspected
  • Structured endoscopic surveillance for selected findings that do not require immediate treatment
08

Risks and safety

Every medical intervention carries risk. Probability varies with the scope of treatment, technique and your individual health.

  • Bleeding, infection or a reaction to sedation
  • A tear or perforation, with risk varying by the intervention
  • Procedure-specific complications discussed during consent
  • Need for observation, repeat endoscopy, radiology or surgery in uncommon cases
09

Results and long-term follow-up

Follow-up is based on histology, depth of invasion, horizontal and vertical margins, lymphovascular involvement and whether the specimen was removed intact. Non-curative features prompt surgical or oncology review; curative resection leads to an organ- and pathology-specific surveillance plan.

Questions you may want to ask your doctor

  • What exact clinical question is this procedure expected to answer?
  • Is the aim diagnosis, treatment, tissue sampling or more than one of these?
  • What are the reasonable alternatives in my case?
  • How should I manage blood thinners, diabetes medicines and fasting?
  • What findings could change the plan during the procedure?
  • When and how will I receive pathology or final results?
!

When should I seek urgent help?

If any of the following occurs, do not wait for a routine web response; seek urgent medical care where you are.

  • Severe or worsening chest or abdominal pain
  • Fever, chills or marked weakness
  • Vomiting blood, black stool or heavy rectal bleeding
  • Breathing difficulty, fainting or confusion
  • Persistent vomiting, inability to drink or increasing abdominal swelling

Press and interviews about this topic

These press items are directly linked to the condition, symptom or procedure on this page.

Press archive →
?

Frequently asked questions

Will it hurt?+

Comfort is planned according to the procedure and your health, often with sedation or anaesthesia support. Expected symptoms and pain relief are explained before discharge.

Can I go home the same day?+

Many procedures are day cases, but the extent of treatment, other illnesses or observation needs can require an overnight stay.

Should I stop my medicines?+

Never stop prescribed medicines on your own. Blood thinners and diabetes medicines require an individual written plan.

When will I receive results?+

Visual findings may be discussed immediately. Biopsy or resection results take longer and should be interpreted with the treating clinician.

i

Author: Doç. Dr. Süleyman Günay
Medical review status: Awaiting physician verification
Last medical review: 2026-09-13
Read our medical content and evidence policy →

R

Scientific References

Official guidelines, scientific articles and patient information sources used for this page. Source links open in a new tab.

  1. ESGE · 2022 · clinical guidelineEndoscopic submucosal dissection for superficial gastrointestinal lesions: ESGE Guideline – Update 2022DOI: 10.1055/a-1811-7025PMID: 35523224
    Open source ↗
  2. ESGE · 2024 · clinical guidelineColorectal polypectomy and endoscopic mucosal resection: ESGE Guideline – Update 2024DOI: 10.1055/a-2304-3219PMID: 38670139
    Open source ↗
  3. ESGE · EHMSG · ESP · 2025 · clinical guidelineManagement of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): ESGE/EHMSG/ESP Guideline update 2025DOI: 10.1055/a-2529-5025PMID: 40112834
    Open source ↗
  4. European Society of Gastrointestinal Endoscopy (ESGE) · Current · guideline libraryClinical Guidelines and Position Statements
    Open source ↗
  5. American Society for Gastrointestinal Endoscopy (ASGE) · Current · guideline libraryASGE Clinical Practice Guidelines
    Open source ↗
  6. Türk Gastroenteroloji Derneği (TGD) · Current · national societyTürk Gastroenteroloji Derneği – Hasta ve Mesleki Bilgi Kaynakları
    Open source ↗
Request an Appointment WhatsApp Academic identity Video